Literature DB >> 21094268

Effectiveness of the Q fever vaccine: a meta-analysis.

G Gefenaite1, J M Munster, R van Houdt, E Hak.   

Abstract

In the Netherlands, the number of notified human Q fever cases showed a steep increase over the last three years and is not expected to disappear in the next few years. Since vaccination might be an option to prevent Q fever cases in the general population, evidence is needed about its effectiveness. We therefore conducted a meta-analysis to determine the evidence base for effectiveness for Q fever vaccination in human populations. We calculated Mantel-Haenszel risk ratios and we used the following formula to calculate the vaccines effectiveness: (1-mhRR) × 100%. Although individual and the pooled estimates showed a high effectiveness of Q fever vaccine, conclusions for the general population cannot be confidently drawn about vaccine effectiveness due to potential flaws in the design of the studies and the selected group of study participants. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094268     DOI: 10.1016/j.vaccine.2010.11.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 2.  Preventive occupational health interventions in the meat processing industry in upper-middle and high-income countries: a systematic review on their effectiveness.

Authors:  Berry J van Holland; Remko Soer; Michiel R de Boer; Michiel F Reneman; Sandra Brouwer
Journal:  Int Arch Occup Environ Health       Date:  2014-08-07       Impact factor: 3.015

3.  Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.

Authors:  Sarah Rebecca Porter; Guy Czaplicki; Jacques Mainil; Raphaël Guattéo; Claude Saegerman
Journal:  Int J Microbiol       Date:  2011-12-13

4.  Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.

Authors:  Emily Sellens; Jacqueline M Norris; Navneet K Dhand; Jane Heller; Lynne Hayes; Heather F Gidding; Harold Willaby; Nicholas Wood; Katrina L Bosward
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

5.  Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.

Authors:  Emily Sellens; Jacqueline M Norris; Navneet K Dhand; Jane Heller; Lynne Hayes; Heather F Gidding; Harold Willaby; Nicholas Wood; Katrina L Bosward
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 6.  Is a One Health Approach Utilized for Q Fever Control? A Comprehensive Literature Review.

Authors:  Md Rezanur Rahaman; Adriana Milazzo; Helen Marshall; Peng Bi
Journal:  Int J Environ Res Public Health       Date:  2019-02-28       Impact factor: 3.390

7.  Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Authors:  Anja Scholzen; Guilhem Richard; Leonard Moise; Laurie A Baeten; Patrick M Reeves; William D Martin; Timothy A Brauns; Christine M Boyle; Susan Raju Paul; Richard Bucala; Richard A Bowen; Anja Garritsen; Anne S De Groot; Ann E Sluder; Mark C Poznansky
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

8.  Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity.

Authors:  Carrie M Long; Paul A Beare; Diane C Cockrell; Jonathan Fintzi; Mahelat Tesfamariam; Carl I Shaia; Robert A Heinzen
Journal:  NPJ Vaccines       Date:  2021-03-19       Impact factor: 7.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.